Patient treatment satisfaction after switching to NovoMix(®) 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors

por Brod, Meryl, Valensi, Paul, Shaban, Joseph A., Bushnell, Don M., Christensen, Torsten L.
Publicado 2010